Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond.


Journal

Trends in molecular medicine
ISSN: 1471-499X
Titre abrégé: Trends Mol Med
Pays: England
ID NLM: 100966035

Informations de publication

Date de publication:
10 2019
Historique:
received: 29 03 2019
revised: 22 05 2019
accepted: 28 05 2019
pubmed: 25 7 2019
medline: 27 6 2020
entrez: 24 7 2019
Statut: ppublish

Résumé

Few therapeutic and diagnostic tools specifically aim at T cells in autoimmune disorders, but are T cells a narrow target in these diseases? Lessons may be learned from celiac disease (CeD), one of the few autoimmune disorders where the T cell driving antigens are known, i.e. dietary gluten proteins. T cell clonotypes specific to gluten are expanded, persist for decades and express a distinct phenotype in CeD patients. Cells with this phenotype are increased also in other autoimmune conditions. Accordingly, disease-specific CD4

Identifiants

pubmed: 31331739
pii: S1471-4914(19)30126-1
doi: 10.1016/j.molmed.2019.05.009
pii:
doi:

Substances chimiques

Glutens 8002-80-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

836-852

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Asbjørn Christophersen (A)

KG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway; Department of Immunology, University of Oslo, Oslo, Norway.

Louise F Risnes (LF)

KG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway; Department of Immunology, University of Oslo, Oslo, Norway.

Shiva Dahal-Koirala (S)

KG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway; Department of Immunology, University of Oslo, Oslo, Norway.

Ludvig M Sollid (LM)

KG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway; Department of Immunology, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway. Electronic address: l.m.sollid@medisin.uio.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH